ArticleDiagnostics (Basel, Switzerland)2023

Post-Coronary Artery Bypass Grafting Outcomes of Patients with/without Type-2 Diabetes Mellitus and Chronic Kidney Disease Treated with SGLT2 Inhibitor Dapagliflozin: A Single-Center Experience Analysis.

Razan Al Namat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.